References
- Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate mono-oxygenase. J Lipid Res 2000;41:163–81
- Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415–23
- Xu X, Zhang XA, Wang DW. The roles of CYP450 epoxygenases andmetabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Adv Drug Deliv Res 2011;63:597–609
- Yang W, Holmes BB, Gopal VR, et al. Characterization of 14,15-epoxyeicosatrienoyl-sulfonamides as 14,15-epoxyeicosatrienoic acid agonists: use for studies of metabolism and ligand binding. J Pharmacol Exp Ther 2007;321:1023–31
- Jiang JG, Chen CL, Card JW, et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res 2005;65:4707–15
- Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999;285:1276–9
- Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for, cardiovascular diseases. Nat Rev Drug Discov 2009;8:794–805
- Cuong NM, Hung TQ, Sung TV, Taylor WC. A new dimeric carbazole alkaloid from Glycsmis stenocarpa roots. Chem Pharm Bull 2004;52:1175–8
- Choi H, Gwak JS, Cho M, et al. Murrayafoline A attenuates the Wnt/β-catenin pathway by promoting the degradation of intracellular β-catenin proteins. Biochem biophys Res Commun 2010;391:915–20
- Lee GH, Oh SJ, Lee SY, et al. Discovery of soluble epoxide hydrolase inhibitors from natural products. Food Chem Toxicol 2014;64:225–30
- Son MJ, Chidipi B, Kim JC, et al. Alterations of contractions and L-type Ca2+ currents by murrayafoline-A in rat ventricular myocytes. Eur J Pharmacol 2014;740:81–7
- Kim JC, Wang J, Son MJ, et al. Sensitization of cardiac Ca(2+) release sites by protein kinase C signaling: evidence from action of murrayafoline A. Pflugers Arch 2014;7:1–15
- Wahidulla S, D’Souza L. Identity of saropeptate, aurantiamide acetate and seperglaucide. Orient J Chem 1998;14:461–2
- Eshbakova KA, Tashkhodzhaev B, Tursunov ZhI, et al. Structure of a new steroid 24S-ergost-4-en-3,6-dione from Aconitum septentrionale. Chem Nat Compd 2011;47:73–5
- Thao NP, Nam NH, Cuong NX, et al. Steroidal constituents from the soft coral sinularia dissecta and their inhibitory effects on lipopolysaccharide-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells. Bull Korean Chem Soc 2013;34:949–52
- Alexander-Lindo RL, Morrison EY, St A, Nair MGN. Hypoglycaemic effect of stigmast-4-en-3-oneand its corresponding alcohol from the bark of Anacardium occidentale (Cashew). Phytother Res 2004;18:403–7
- Viswanadh GS, Ramaiah PA, Latsch H, Maskey R. Chemical constituents of the heartwood and bark of Homonoia riparia. J Trop Med Plants 2006;7:267–73
- Bȍhme F, Schmidt J, Sung TV, Adam G. 24-Methylpollinastanone, related triterpenoids and sterols from Costus tonkinesis. Phytochemistry 1997;4:1041–4
- Yang P, Liu D-Q, Lee T-J, et al. Bioactive constituents from the green alga Caulerpa racemosa. Bioorg Med Chem 2015;23:38–45
- Muraoka O, Morikawa T, Zhang Y, et al. Novel megastigmanes with lipid accumulation inhibitory and lipid metabolism-promoting activities in HepG2 cells from Sedum sarmentosum. Tetrahedron 2009;65:4142–8
- Ma Q-G, Wang Y-G, Liu W-M, et al. Hepatoprotective sesquiterpenes and rutinosides from Murraya koeigii (L.) spreng. J Agric Food Chem 2014;62:4145–51